Home

Piramal Pharma Ltd Quarterly Result

Image

Piramal Pharma Ltd

NSE: PPLPHARMA

Net Profit - Last Quarter

₹ 153.5 Cr.

Last updated on: May 27, 2025

Piramal Pharma Ltd Quarterly Results Key Highlights

  • The revenue of Piramal Pharma Ltd for the Mar '25 is ₹ 2812 crore as compare to the Dec '24 revenue of ₹ 2233 crore.
  • This represent the growth of 25.92%a1# The ebitda of Piramal Pharma Ltd for the Mar '25 is ₹ 619.24 crore as compare to the Dec '24 ebitda of ₹ 366.92 crore.
  • This represent the growth of 68.77%a1# The net profit of Piramal Pharma Ltd for the Mar '25 is ₹ 153.5 crore as compare to the Dec '24 net profit of ₹ 3.68 crore.
  • This represent the growth of 4071%a1#.

Piramal Pharma Ltd Quarterly Results Analysis

Market Price of Piramal Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Piramal Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
27 May 2025203.35
26 May 2025205.25
23 May 2025205.45
22 May 2025206.35
21 May 2025206.15
20 May 2025205.75
19 May 2025205.6
16 May 2025205
15 May 2025208.55
14 May 2025219

Historical Revenue of Piramal Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Piramal Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Piramal Pharma Ltd

No data available

* All values are in crore

Piramal Pharma Ltd News Hub

Piramal Pharma receives SBTi validation for its GHG commitment

Piramal Pharma has embarked on its sustainability journey as the Science Based Targets initiative (S

Read more

17 Sept 24

Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization

Read more

30 Sept 24

Piramal Pharma to discuss results

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2025. Powe

Read more

14 Jan 25

Piramal Pharma to declare Quarterly Result

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 23 October 2024. Powe

Read more

15 Oct 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Oct 2024

PPT

Sep 2024

PPT

July 2024

TranscriptPPT

Feb 2023

Transcript

Jan 2023

PPT

Nov 2022

Transcript

FAQs for Quarterly Results of Piramal Pharma Ltd

What key financial metrics are included in Piramal Pharma Ltd's quarterly results?

Key financial metrics in Piramal Pharma Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Piramal Pharma Ltd announce its quarterly results?

Piramal Pharma Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Piramal Pharma Ltd's quarterly performance impact its stock price?

Piramal Pharma Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Piramal Pharma Ltd's quarterly results on dividends?

The impact of Piramal Pharma Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Piramal Pharma Ltd's quarterly results?

Yes, Piramal Pharma Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions